Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
Robert Challen, postdoctoral research associate123, Ellen Brooks-Pollock, senior lecturer in veterinary public health345, Jonathan M
Robert Challen, postdoctoral research associate123, Ellen Brooks-Pollock, senior lecturer in veterinary public health345, Jonathan M
The obstacle trials goal to accelerate the development of COVID-19 vaccines.Credit history: Andrey Rudakov/Bloomberg/Getty Youthful,